Recent analysis of Ducommun (DCO) has focused on a declining backlog, shrinking operating margins, and breakeven free cash flow. These factors appear to have shaped sentiment around the stock’s latest move.

The share price has eased in the very short term, with a 1 month share price return of 4.73% and a 1 day move of 0.53%. However, the 90 day share price return of 25.21% and 1 year total shareholder return of 106.57% point to momentum building over a longer horizon as the market reassesses both growth prospects and risks around the contracting backlog and margin pressure.

If Ducommun’s recent move has your attention, it could be a good moment to broaden your search and check out 20 top founder-led companies

With Ducommun trading at US$120.78 and sitting at a discount to both analyst price targets and some intrinsic estimates despite pressure on backlog, margins, and cash flow, is this recent surge a buying opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 15.9% Undervalued

Against the last close of $120.78, the most followed narrative points to a fair value of $143.60, framing Ducommun as meaningfully undervalued and heavily tied to defense and aerospace trends.

Elevated global defense spending and the replenishment of missile and radar inventories highlighted by strong double digit growth in both segments and a 30% increase in missile backlog positions Ducommun to sustain and expand revenue as defense modernization accelerates over the next several years, with increasing program content and order activity.

Curious how this defense heavy story turns into a higher fair value? The narrative leans on revenue growth, margin rebuild, and a richer future earnings multiple. The exact mix of assumptions might surprise you.

Result: Fair Value of $143.60 (UNDERVALUED)

However, this depends heavily on defense orders staying on track and facility consolidation going smoothly, since program hiccups or execution setbacks could quickly challenge that 15.9% undervaluation story.

Another Way To Look At Valuation

The main narrative leans on fair value and intrinsic estimates, but the simple P/S ratio tells a more mixed story. Ducommun trades on a P/S of 2.2x versus a fair ratio of 1.1x, even though the US Aerospace & Defense average sits at 4.4x and peers at 3.8x. Is the premium to that fair ratio a sign of extra risk, or a price the market is already comfortable paying for this story?

Next Steps

If this mix of optimism and concern feels familiar, do not wait too long to stress test it against the numbers yourself and weigh both sides with 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Ducommun is already on your radar, do not stop there, broaden your watchlist with focused stock ideas built from clear data and fundamentals.

• Prioritize resilience and sleep easier at night by scanning 67 resilient stocks with low risk scores to see which companies score well on risk metrics and balance sheet strength.
• Hunt for quality at a reasonable price by checking 61 high quality undervalued stocks where strong fundamentals and pricing may line up more attractively than the headline suggests.
• Target companies with solid footing by reviewing the solid balance sheet and fundamentals stocks screener (39 results) and see which names pair financial stability with the potential for durable performance.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.